The increased number of subjects with type 2 diabetes and putting into clinical practice further new hypoglycemic agents and also aspiring to achieve the bettest glycemic control using a few medications may cause that undesirable actions of these agents may be observed more frequently. One undesirable effect of hypoglycemic drugs is acute pancreatitis; therefore the aim of the present paper is to review data concerning the development of this complication during type 2 diabetes pharmacotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5604/17322693.964936 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!